¼¼°èÀÇ »êºÎÀΰú EHR ½ÃÀå
OBGYN EHR
»óǰÄÚµå : 1788216
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 284 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,215,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ®ÀÇ º¹»ç ¹× ºÙ¿©³Ö±â´Â °¡´ÉÇÏÁö¸¸, Ç¥/±×·¡ÇÁ µîÀº º¹»çÇÒ ¼ö ¾ø½À´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,647,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ¹× 100% ÀÚȸ»çÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1Àδç 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ »êºÎÀΰú EHR ½ÃÀåÀº 2030³â±îÁö 30¾ï ´Þ·¯¿¡ µµ´Þ

2024³â¿¡ 19¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ »êºÎÀΰú EHR ½ÃÀåÀº 2024-2030³â¿¡ CAGR 8.5%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 30¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ À¥±â¹Ý HERÀº CAGR 10.0%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á±îÁö 20¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Ŭ¶óÀÌ¾ðÆ®¼­¹ö ±â¹Ý HER ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 5.8%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº ÃßÁ¤ 5¾ï 710¸¸ ´Þ·¯, Áß±¹Àº CAGR 13.5%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ »êºÎÀΰú EHR ½ÃÀåÀº 2024³â¿¡ 5¾ï 710¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGR 13.5%·Î ÃßÀÌÇϸç, 2030³â¿¡´Â 6¾ï 6,680¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 4.2%¿Í 8.2%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 5.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ »êºÎÀΰú EHR ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¿©¼º ÀÇ·á ÇöÀå¿¡¼­ »êºÎÀΰú EHR ½Ã½ºÅÛ ¼ö¿ä°¡ ±ÞÁõÇÏ´Â ÀÌÀ¯´Â?

¿©¼º ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õµéÀÌ »êºÎÀΰú °íÀ¯ÀÇ ÀÓ»ó ¿öÅ©Ç÷ο쿡 ¸Â´Â µðÁöÅÐ ¼Ö·ç¼ÇÀ» ¿ä±¸ÇÔ¿¡ µû¶ó »êºÎÀΰú Àü¹® ÀüÀڰǰ­±â·Ï(EHR) ½Ã½ºÅÛ µµÀÔÀÌ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¹ü¿ë EHR Ç÷§Æû°ú ´Þ¸® »êºÎÀΰú¿¡ ƯȭµÈ ½Ã½ºÅÛÀº ÀÏ»óÀûÀÎ ºÎÀΰú °ËÁø ¹× »êÀü ÁøÂûºÎÅÍ ºÐ¸¸ ±â·Ï, »êÈÄ ÃßÀû °ü¸®, ºÒÀÓ Ä¡·á±îÁö ¸ðµç Áø·á¸¦ °ü¸®ÇÒ ¼ö ÀÖµµ·Ï ¼³°èµÇ¾î ÀÖ½À´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº Á¾ÇÕÀûÀΠȯÀÚ °ü¸®¿¡ ÇʼöÀûÀÎ »ê°ú º´·Â, ÅÂ¾Æ ¸ð´ÏÅ͸µ, »ý¸® ÁÖ±â ÃßÀû, °íÀ§Çè Àӽаü¸®¸¦ À§ÇÑ ¸ÂÃãÇü ÅÛÇø´À» Á¦°øÇÔÀ¸·Î½á ÀÓ»ó ÇÁ·Î¼¼½º¸¦ °£¼ÒÈ­ÇÕ´Ï´Ù. ¶ÇÇÑ ÅëÇÕµÈ ½ºÄÉÁÙ¸µ Åø, CPT/ICD-10 ÀÚµ¿ ÄÚµù, ȯÀÚº° Áø·á °æ·Î¸¦ ÅëÇØ ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ´Â ¾÷¹« È¿À²¼ºÀ» ³ôÀ̰í ÁøÈ­ÇÏ´Â ÀÇ·á ±ÔÁ¦¸¦ ÁؼöÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶Ç ´Ù¸¥ Áß¿äÇÑ ¿øµ¿·ÂÀº °¡Ä¡ ±â¹Ý Áø·á¿Í »ê¸ð °Ç°­ÀÇ °á°ú ÃßÀû¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î, °­·ÂÇÑ µ¥ÀÌÅÍ ºÐ¼® ±â´ÉÀÌ ÇÊ¿äÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Ç÷§Æû¿¡´Â ÀÓ»óÀǰ¡ ±Ù°Å¿¡ ±â¹ÝÇÑ °¡À̵å¶óÀÎÀ» ÁؼöÇÏ°í »ý½Ä °Ç°­ ¹× »ê¸ð °Ç°­ °á°ú¸¦ °³¼±ÇÏ´Â µ¥ µµ¿òÀÌ µÇ´Â ÀÓ»óÀû ÆÇ´Ü Áö¿ø ÅøÀÌ ³»ÀåµÇ¾î ÀÖ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ÇコÄɾî´Â ȯÀÚ Á᫐ ¸ðµ¨·Î ÀüȯÇϰí ÀÖÀ¸¸ç, ¿ø°ÝÀÇ·á, ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ, ¾ÈÀüÇÑ È¯ÀÚ Æ÷ÅÐÀ» Áö¿øÇÏ´Â ÀÌ·¯ÇÑ ½Ã½ºÅÛÀÇ ´É·ÂÀº ÇʼöÀûÀÔ´Ï´Ù. ºÒÀÓ Ä¡·á, Àӽżº ´ç´¢, »êÀü ÇÕº´Áõ Áõ°¡´Â Áø·á¸¦ ´õ¿í ¼¼¹ÐÇϰí Á¾´ÜÀûÀÎ Äɾî Ç÷£¿¡ ´ëÀÀÇÒ ¼ö ÀÖ´Â EHR·Î ²ø¾î¿Ã¸®°í ÀÖ½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î Àü¹® ºÐ¾ß¿¡ ƯȭµÈ »êºÎÀΰú EHR ¼Ö·ç¼ÇÀÇ µîÀåÀº ÇコÄÉ¾î ºÐ¾ß¿¡¼­ Àü¹® ºÐ¾ß¿¡ ƯȭµÈ µðÁöÅÐ ÀÎÇÁ¶ó·ÎÀÇ ±¤¹üÀ§ÇÑ ÀüȯÀ» ¹Ý¿µÇÕ´Ï´Ù.

±ÔÁ¦ ±âÁذú ÇコÄÉ¾î °³ÇõÀº »êºÎÀΰú EHR µµÀÔ¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÄ¡°í Àִ°¡?

¼¼°è »êºÎÀΰú EHR ½ÃÀåÀº ¿©¼º ÀÇ·á Çö´ëÈ­¸¦ À§ÇÑ ±ÔÁ¦, »óȯ, »óÈ£¿î¿ë¼º Àǹ«È­ÀÇ ¹°°á·Î ÀÎÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ¹Ì±¹¿¡¼­´Â 21¼¼±â Ä¡·á¹ý(21st Century Cures Act)°ú ONCÀÇ ÀÇ·á IT ÀÎÁõ ÇÁ·Î±×·¥(Health IT Certification Program) Áؼö¿¡ µû¶ó ½Ã½ºÅÛ¿¡ Ç¥ÁØÈ­µÈ API, µ¥ÀÌÅÍ °øÀ¯, ȯÀÚ Á¢±ÙÀ» Áö¿øÇϵµ·Ï ¿ä±¸Çϰí ÀÖÀ¸¸ç, ÀÌ ¸ðµç °ÍÀÌ »êºÎÀΰú EHR Ç÷§ÆûÀÇ Á¶´Þ ±âÁØ¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ÀÌ ¸ðµç °ÍÀÌ »êºÎÀΰú EHR Ç÷§ÆûÀÇ Á¶´Þ ±âÁØ¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ÇÑÆí, Meaningful Use¿Í MIPS(Merit-Based Incentive Payment System) ÇÁ·Î±×·¥Àº ¼Ò±Ô¸ð Ŭ¸®´Ð¿¡¼­µµ ǰÁú º¸°í¿Í Áý´Ü °Ç°­ ÃßÀûÀ» °¡´ÉÇÏ°Ô ÇÏ´Â ÀÎÁõµÈ EHRÀ» äÅÃÇϵµ·Ï Àå·ÁÇϰí ÀÖ½À´Ï´Ù. ƯÈ÷ ¹Ì±¹À̳ª ¿µ±¹°ú °°Àº ±¹°¡¿¡¼­´Â »ê¸ð »ç¸Á·ü°ú »êÀü °ü¸®ÀÇ ÀÎÁ¾ °£ °ÝÂ÷¸¦ ÁÙÀ̱â À§ÇÑ »õ·Î¿î ¹ý·üÀÌ Á¦Á¤µÇ¾ú±â ¶§¹®ÀÔ´Ï´Ù. ¶ÇÇÑ º¸Çè ½ÃÀåÀÇ º¸»ó °³ÇõÀ¸·Î ÀÎÇØ ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õµéÀº û±¸ ó¸®, ¹®¼­È­, ¸®½ºÅ© ½ºÄھÀ» ÃÖÀûÈ­ÇÏ´Â ÅëÇÕ ¼Ö·ç¼ÇÀ¸·Î ÀüȯÇϰí ÀÖ½À´Ï´Ù. ±¹Á¦ÀûÀ¸·Î´Â Á¤ºÎÀÇ Àμ¾Æ¼ºê¿Í ¹Î°ü ÆÄÆ®³Ê½Ê°ú ÇÔ²² ½ÅÈï ±¹°¡ÀÇ µðÁöÅÐ Çコ ÀÎÇÁ¶ó ±¸ÃàÀÌ ÁøÇàµÇ¸é¼­ Ŭ¶ó¿ìµå ±â¹Ý »êºÎÀΰú EHR º¥´õµéÀÌ ¹Ì°³¹ß ½ÃÀå¿¡ ÁøÀÔÇÒ ¼ö ÀÖ´Â ±âȸ°¡ »ý±â°í ÀÖ½À´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿Í À¯´Ï¼¼ÇÁ(UNICEF)ÀÇ ÀÓ»êºÎ ¹× »ý½Ä °Ç°­(¼º ¹× »ý½Ä °ü·Ã °Ç°­) °á°ú¸¦ ¸ñÇ¥·Î ÇÏ´Â ¼¼°è °Ç°­ ±¸»óÀº ½Å·ÚÇÒ ¼ö ÀÖ´Â Á¾´ÜÀû °Ç°­ µ¥ÀÌÅÍÀÇ Çʿ伺À» ´õ¿í °­Á¶Çϰí ÀÖ½À´Ï´Ù. ±× °á°ú, º¥´õµéÀº ±ÔÁ¦ Áؼö»Ó¸¸ ¾Æ´Ï¶ó ÇÁ¶óÀ̹ö½Ã, µ¥ÀÌÅÍ ¹«°á¼º, ¿©¼º °Ç°­ÀÇ ÀÓ»óÀû ƯÀ̼º¿¡ ´ëÇÑ ±â´ëÄ¡¸¦ ¶Ù¾î³Ñ±â À§ÇØ °æÀïÇϰí ÀÖ½À´Ï´Ù.

±â¼ú Çõ½ÅÀº »êºÎÀΰú º´¿øÀÇ µðÁöÅÐ ¿î¿µÀ» °³ÇõÇϴ°¡?

»êºÎÀΰú EHR ½ÃÀåÀÇ ±â¼ú Çõ½ÅÀº ÀÇ·áÁøÀÌ Áø·á¸¦ Á¦°øÇϰí, µ¥ÀÌÅ͸¦ °ü¸®Çϰí, ȯÀÚ¿Í ¼ÒÅëÇÏ´Â ¹æ½ÄÀ» º¯È­½Ã۰í ÀÖ½À´Ï´Ù. ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´× ¾Ë°í¸®ÁòÀº ÇöÀç ÀӽŠÀ§Çè ¿¹ÃøÀ» µ½°í, ÃÊÀ½ÆÄ À̹ÌÁö¸¦ ºÐ¼®Çϰí, ´ë±Ô¸ð µ¥ÀÌÅͼ¼Æ®¸¦ ±â¹ÝÀ¸·Î Áø´Ü °æ·Î¸¦ ÃßõÇϱâ À§ÇØ ÅëÇյǰí ÀÖ½À´Ï´Ù. À½¼º ÀÎ½Ä ¹× ÀÚ¿¬ ¾ð¾î ó¸®(NLP) Åøµµ ¹®¼­ ÀÛ¼º¿¡ Çõ¸íÀ» ÀÏÀ¸Å°°í ÀÖÀ¸¸ç, ÀÓ»óÀÇ´Â Áø·á ¹× ºÐ¸¸ ȸÁø Áß¿¡ ÇÚÁîÇÁ¸®·Î Áø·á±â·ÏÀ» ÀÛ¼ºÇÒ ¼ö ÀÖÀ¸¸ç, ±ÍÁßÇÑ ½Ã°£À» Àý¾àÇϰí ÀÇ»çÀÇ ¼ÒÁøÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ¸ð¹ÙÀÏ ÆÛ½ºÆ® Ç÷§ÆûÀº ƯÈ÷ ȯÀÚ ¼ö°¡ ¸¹Àº Áø·á¼Ò¿¡¼­ ³Î¸® º¸±ÞµÇ°í ÀÖÀ¸¸ç, ÇÚµåÇïµå µð¹ÙÀ̽º¸¦ ÅëÇØ ÅÂ¾Æ ¸ð´ÏÅ͸µ µ¥ÀÌÅÍ, ó¹æÀü º¸Ãæ, °Ë»ç °á°ú¸¦ ½Ç½Ã°£À¸·Î È®ÀÎÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶Ç ´Ù¸¥ Áß¿äÇÑ ¹ßÀüÀº »ê¸ðÀÇ ½É¹Ú¼ö, ¼ö¸é ÁÖ±â, ½Åü Ȱµ¿°ú °°Àº ¿þ¾î·¯ºí ±â±â µ¥ÀÌÅ͸¦ EHR ´ë½Ãº¸µå¿¡ ÅëÇÕÇÏ¿© º¸´Ù °³ÀÎÈ­µÈ ÀÓ»êºÎ °ü¸®¸¦ °¡´ÉÇÏ°Ô ÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀû º¯È­´Â ´ÙÁ÷Á¾ ÆÀ °£ÀÇ ´õ ³ªÀº Çù·Â °ü°è¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î ÇöÀç »êºÎÀΰú EHR¿¡´Â ÀϹÝÀÇ, ºÒÀÓ Àü¹®ÀÇ, ¿µ»óÀÇÇаú Àü¹®ÀÇ, ¼Ò¾Æ°ú Àü¹®ÀÇ °£ÀÇ ¿øÈ°ÇÑ ÀüȯÀ» ÃËÁøÇÏ´Â ÀÇ·Ú °ü¸® ÅøÀÌ Æ÷ÇԵǾî ÀÖ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ¶ÇÇÑ Ãªº¿, ÀÚµ¿ ¸®¸¶Àδõ, ´Ù±¹¾î ÀÎÅÍÆäÀ̽º¿Í °°Àº ȯÀÚ Âü¿© Åøµµ Ç¥ÁØÀÌ µÇ¾î°¡°í ÀÖÀ¸¸ç, »êÀü ¿¹¾à ¹× »êÈÄ °ü¸®ÀÇ ¼øÀÀµµ¸¦ Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ »óÈ£ ¿î¿ë °¡´ÉÇÑ Å¬¶ó¿ìµå ±â¹Ý ½Ã½ºÅÛÀ¸·ÎÀÇ ÀüȯÀ» ÅëÇØ Áø·á¼Ò ±Ô¸ð È®´ë, À§¼º Áø·á¼Ò °³¼³, ¿©·¯ Áö¿ª¿¡ °ÉÄ£ Áø·á Á¦°ø °ü¸®°¡ ¿ëÀÌÇØÁ³½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀÌ °áÇÕµÇ¾î »êºÎÀΰú º´¿øÀº µðÁöÅÐÀûÀ¸·Î ¼º¼÷ÇÑ È¯ÀÚ Áß½ÉÀÇ Áø·á ȯ°æÀ¸·Î º¯¸ðÇϰí ÀÖÀ¸¸ç, Çö´ëÀÇ º¹ÀâÇÑ »ý½Ä °Ç°­(¼º ¹× »ý½Ä °ü·Ã °Ç°­)¿¡ ´ëÀÀÇÒ ¼ö Àִ üÁ¦¸¦ °®Ãß°í ÀÖ½À´Ï´Ù.

¼¼°è »êºÎÀΰú EHR ½ÃÀåÀÇ ±Þ¼ºÀå ¿øµ¿·ÂÀº?

»êºÎÀΰú EHR ½ÃÀåÀÇ ¼ºÀå¿¡´Â ÀÓ»ó ±â¼úÀÇ ¹ßÀü, Áø·á ¸ðµ¨ÀÇ ÁøÈ­, Àü¹® ºÐ¾ß¿¡ ƯȭµÈ ±â´É¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µî ¿©·¯ °¡Áö ¿äÀÎÀÌ ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ù°, ºÒÀÓ Ä¡·á ÁÖ±â Áõ°¡, °íÀ§Çè ÀÓ½Å, Àå±âÀûÀÎ »ý½Ä ÀÇ·á ÃßÀû µî ¿©¼ºÀÇ °Ç°­ ¿ä±¸°¡ º¹ÀâÇØÁü¿¡ µû¶ó Ŭ¸®´ÐÀº ³ôÀº ÀÓ»óÀû Á¤È®µµ·Î Á¾ÇÕÀûÀÎ ¿¡ÇÇ¼Òµå °ü¸®¸¦ °ü¸®ÇÒ ¼ö ÀÖ´Â Ç÷§ÆûÀ» µµÀÔÇØ¾ß ÇÕ´Ï´Ù. µÑ°, ¿ø°ÝÀÇ·á°¡ Ç¥ÁØ Áø·á¿¡ ÅëÇյǸ鼭, ƯÈ÷ ÆÒµ¥¹Í ÀÌÈÄ »êºÎÀΰú Áø·á¿¡ ¸ÂÃá °¡»ó Áø·á ±â´ÉÀ» °®Ãá EHR¿¡ ´ëÇÑ °­·ÂÇÑ ¼ö¿ä°¡ »ý°Ü³ª°í ÀÖ½À´Ï´Ù. ÀÚ±Ã°æ °Ë»ç, º¹°­°æ °Ë»ç µî ÃÖ¼Ò Ä§½À ¼ö¼úÀ» Àü¹®À¸·Î ÇÏ´Â ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC) Áõ°¡µµ ¼ö¼ú ÀüÈÄÀÇ ¹®¼­È­ ¹× ȸº¹ ¸ð´ÏÅ͸µ¿¡ ´ëÀÀÇÒ ¼ö ÀÖ´Â EHRÀÇ µµÀÔÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¼Â°, ¼ÒºñÀÚ ÇൿÀÌ º¯È­Çϰí ÀÖÀ¸¸ç, ȯÀÚµéÀº ½Ç½Ã°£ Ä¿¹Â´ÏÄÉÀ̼Ç, °£ÆíÇÑ ¿¹¾à ÀÏÁ¤, °Ë»ç °á°ú ¾×¼¼½º, µðÁöÅÐ À£ºù ÃßÀûÀ» ±â´ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ »ç¸ðÆÝµå¿Í ÀÇ·á ³×Æ®¿öÅ© »çÀÌ¿¡¼­ »êºÎÀΰú Áø·á¼Ò ÅëÇÕ¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖÀ¸¸ç, Ç¥ÁØÈ­µÈ EHR Ç÷§ÆûÀº û±¸, º¸°í, ÄÄÇöóÀ̾𽺸¦ Áß¾Ó ÁýÁßÈ­ÇÒ ¼ö ÀÖ´Â ÀÌ Àü·«ÀÇ Áß½ÉÀÌ µÇ°í ÀÖ½À´Ï´Ù. ±â¼úÀûÀ¸·Î´Â Ŭ¶ó¿ìµå µµÀÔ ¸ðµ¨ÀÌ Áß¼ÒÇü Ŭ¸®´ÐÀÇ ÁøÀÔÀ庮À» ³·Ãß°í, ÀÎÇÁ¶ó¿¡ ¸¹Àº ÅõÀÚ¸¦ ÇÏÁö ¾Ê°íµµ °í±Þ Åø¿¡ Á¢±ÙÇÒ ¼ö ÀÖµµ·Ï Çϰí ÀÖ½À´Ï´Ù. ¸¶Áö¸·À¸·Î °ø±Þ¾÷ü °£ °æÀïÀÌ Ä¡¿­ÇØÁö¸é¼­ ÃÖÁ¾»ç¿ëÀÚ¿¡ ´ëÇÑ °¡°Ý Ã¥Á¤, ±â¼ú Çõ½Å, °í°´ Áö¿øÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿òÁ÷ÀÓÀÌ ¸Â¹°¸®¸é¼­ ´ëÀÀ °¡´ÉÇÑ ½ÃÀåÀÌ ºü¸£°Ô È®´ëµÇ°í ÀÖÀ¸¸ç, »êºÎÀΰú¿¡ ƯȭµÈ EHR ½Ã½ºÅÛÀÌ ¹Ì·¡ ¿©¼º °Ç°­°ü¸® Á¦°øÀÇ ÇÙ½É µðÁöÅÐ ÀÚ»êÀÌ µÉ °ÍÀÓÀÌ È®½Ç½ÃµÇ°í ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç°(À¥ ±â¹Ý HER, Ŭ¶óÀÌ¾ðÆ®¼­¹ö ±â¹Ý HER), ¾ÖÇø®ÄÉÀ̼Ç(¿öÅ©ÇÃ·Î¿ì °ü¸® ¾ÖÇø®ÄÉÀ̼Ç, ½ºÄÉÁÙ¸µ ¾ÖÇø®ÄÉÀ̼Ç, û±¸ ¾ÖÇø®ÄÉÀ̼Ç, ÀÓ»ó ±â·Ï ¾ÖÇø®ÄÉÀ̼Ç, ±âŸ ¾ÖÇø®ÄÉÀ̼Ç)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾ç ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è µµ¸ÞÀÎ Àü¹®°¡·ÎºÎÅÍ Å¥·¹ÀÌÆ®µÈ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global OBGYN EHR Market to Reach US$3.0 Billion by 2030

The global market for OBGYN EHR estimated at US$1.9 Billion in the year 2024, is expected to reach US$3.0 Billion by 2030, growing at a CAGR of 8.5% over the analysis period 2024-2030. Web-based HER, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$2.0 Billion by the end of the analysis period. Growth in the Client Server-based HER segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$507.1 Million While China is Forecast to Grow at 13.5% CAGR

The OBGYN EHR market in the U.S. is estimated at US$507.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$666.8 Million by the year 2030 trailing a CAGR of 13.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.2% and 8.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.7% CAGR.

Global OBGYN EHR Market - Key Trends & Drivers Summarized

Why Is the Demand for Specialized OBGYN EHR Systems Surging Across Women’s Health Practices?

The adoption of specialized OBGYN electronic health record (EHR) systems is gaining significant momentum as women’s healthcare providers seek tailored digital solutions that align with the unique clinical workflows of obstetrics and gynecology. Unlike general-purpose EHR platforms, OBGYN-specific systems are designed to manage the full spectrum of care-from routine gynecological exams and prenatal visits to labor and delivery documentation, postnatal follow-ups, and fertility treatments. These systems streamline clinical processes by offering customizable templates for obstetric histories, fetal monitoring, menstrual cycle tracking, and high-risk pregnancy management, all of which are essential for comprehensive patient care. Additionally, integrated scheduling tools, automated coding for CPT/ICD-10, and patient-specific care pathways enable providers to enhance operational efficiency and ensure compliance with evolving healthcare regulations. Another critical driver is the increasing demand for value-based care and outcome tracking in maternal health, which necessitates robust data analytics capabilities-features that many modern OBGYN EHR systems now offer. These platforms often come with embedded clinical decision support tools that help clinicians adhere to evidence-based guidelines and improve outcomes in reproductive and maternal health. As healthcare transitions to more patient-centric models, the ability of these systems to support telehealth, remote patient monitoring, and secure patient portals has become essential. The rise in fertility treatments, gestational diabetes, and prenatal complications is further pushing practices toward EHRs that can handle nuanced, longitudinal care plans. Altogether, the rise of specialized OBGYN EHR solutions reflects a broader shift toward subspecialty-focused digital infrastructure in healthcare.

How Are Regulatory Standards and Healthcare Reforms Impacting OBGYN EHR Adoption?

The global OBGYN EHR market is being reshaped by a wave of regulatory, reimbursement, and interoperability mandates aimed at modernizing women’s health practices. In the United States, compliance with the 21st Century Cures Act and ONC’s Health IT Certification Program requires systems to support standardized APIs, data sharing, and patient access, all of which are influencing the procurement criteria for EHR platforms in obstetrics and gynecology. Meanwhile, Meaningful Use and MIPS (Merit-Based Incentive Payment System) programs have nudged even smaller clinics to adopt certified EHRs that allow for quality reporting and population health tracking-functions that general EHRs often fail to deliver effectively for OBGYN-specific metrics. The emphasis on maternal health equity is also fueling adoption, particularly as new legislation in countries like the U.S. and U.K. channels funding toward reducing maternal mortality and racial disparities in prenatal care. Additionally, reimbursement reform in insurance markets is pushing providers toward integrated solutions that optimize claims processing, documentation, and risk scoring-areas where specialty-focused EHRs offer significant value. Internationally, the rollout of digital health infrastructure in emerging economies, coupled with government incentives and public-private partnerships, is creating opportunities for cloud-based OBGYN EHR vendors to enter underserved markets. Global health initiatives by WHO and UNICEF targeting maternal and reproductive health outcomes are further reinforcing the need for reliable, longitudinal health data-something best captured through purpose-built EHR systems. As a result, vendors are not only racing to meet regulatory compliance but also to exceed expectations around privacy, data integrity, and clinical specificity in women’s health.

Is Technology Innovation Reinventing How OBGYN Clinics Operate Digitally?

Innovation in the OBGYN EHR market is transforming how providers deliver care, manage data, and interact with patients. Artificial intelligence (AI) and machine learning algorithms are now being integrated to assist with risk prediction in pregnancies, analyze ultrasound imaging, and recommend diagnostic pathways based on large datasets. Voice recognition and natural language processing (NLP) tools are also revolutionizing documentation, allowing clinicians to chart hands-free during exams or labor rounds, saving valuable time and reducing physician burnout. Mobile-first platforms have become especially popular in high-volume practices, enabling real-time access to fetal monitoring data, prescription refills, and lab results from handheld devices. Another significant advancement is the integration of wearable device data-such as maternal heart rate, sleep cycles, and physical activity-into EHR dashboards, enabling more personalized prenatal care. These technological shifts are also fostering better collaboration across multidisciplinary teams. For instance, OBGYN EHRs now often include referral management tools to facilitate seamless transitions between generalists, fertility specialists, radiologists, and pediatricians. Patient engagement tools like chatbots, automated reminders, and multilingual interfaces are also becoming standard, improving adherence to prenatal appointments and postnatal care. Additionally, the move to interoperable, cloud-based systems has made it easier for practices to scale, open satellite clinics, or manage care delivery across multiple geographic locations. Collectively, these innovations are reshaping OBGYN clinics into digitally mature, patient-centered care environments that are better equipped to meet the complexities of modern reproductive health.

What’s Fueling the Rapid Growth of the Global OBGYN EHR Market?

The growth in the OBGYN EHR market is driven by several factors related to advancements in clinical technology, evolving care models, and heightened demand for specialty-specific functionality. First, the increasing complexity of women’s health needs-including rising fertility treatment cycles, high-risk pregnancies, and long-term reproductive health tracking-is pushing clinics to adopt platforms capable of managing comprehensive, episodic care with high clinical precision. Second, the integration of telehealth into standard practice, especially post-pandemic, has created a strong demand for EHRs with virtual care capabilities tailored to prenatal and gynecological consultations. The growth of outpatient surgical centers specializing in minimally invasive procedures such as hysteroscopies and laparoscopies is also encouraging the adoption of EHRs that can handle perioperative documentation and recovery monitoring. Third, consumer behavior is shifting, with patients expecting real-time communication, easy appointment scheduling, access to test results, and digital wellness tracking-all of which require robust patient portal integration. Additionally, there is growing interest among private equity and health networks in consolidating OBGYN practices, and standardized EHR platforms are central to this strategy for enabling centralized billing, reporting, and compliance. On the technology front, cloud deployment models are lowering entry barriers for small and mid-sized practices, allowing them to access sophisticated tools without investing heavily in infrastructure. Finally, vendor competition has intensified, leading to better pricing, innovation, and customer support for end-users. These interlocking trends are rapidly expanding the addressable market and ensuring that OBGYN-specific EHR systems become a core digital asset in the future of women’s healthcare delivery.

SCOPE OF STUDY:

The report analyzes the OBGYN EHR market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Web-based HER, Client Server-based HER); Application (Workflow Management Application, Scheduling Application, Billing Application, Clinical Documentation Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â